BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 25344051)

  • 1. Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins.
    Zou A; Lambert D; Yeh H; Yasukawa K; Behbod F; Fan F; Cheng N
    BMC Cancer; 2014 Oct; 14():781. PubMed ID: 25344051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2/3 and Suppression of HGF/c-Met Signaling Mechanisms.
    Fang WB; Mafuvadze B; Yao M; Zou A; Portsche M; Cheng N
    PLoS One; 2015; 10(8):e0135063. PubMed ID: 26252654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL1 Derived from Mammary Fibroblasts Promotes Progression of Mammary Lesions to Invasive Carcinoma through CXCR2 Dependent Mechanisms.
    Bernard S; Myers M; Fang WB; Zinda B; Smart C; Lambert D; Zou A; Fan F; Cheng N
    J Mammary Gland Biol Neoplasia; 2018 Dec; 23(4):249-267. PubMed ID: 30094610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
    Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD26 expression is attenuated by TGF-β and SDF-1 autocrine signaling on stromal myofibroblasts in human breast cancers.
    Mezawa Y; Daigo Y; Takano A; Miyagi Y; Yokose T; Yamashita T; Morimoto C; Hino O; Orimo A
    Cancer Med; 2019 Jul; 8(8):3936-3948. PubMed ID: 31140748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.
    Divella R; Daniele A; Savino E; Palma F; Bellizzi A; Giotta F; Simone G; Lioce M; Quaranta M; Paradiso A; Mazzocca A
    Anticancer Res; 2013 Apr; 33(4):1491-7. PubMed ID: 23564790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal ING1 expression induces a secretory phenotype and correlates with breast cancer patient survival.
    Thakur S; Nabbi A; Klimowicz A; Riabowol K
    Mol Cancer; 2015 Aug; 14():164. PubMed ID: 26306560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of chemokine C-C ligand 2 in stroma is associated with recurrent basal-like breast cancers.
    Yao M; Yu E; Staggs V; Fan F; Cheng N
    Mod Pathol; 2016 Aug; 29(8):810-23. PubMed ID: 27125354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
    Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct nuclear receptor expression in stroma adjacent to breast tumors.
    Knower KC; Chand AL; Eriksson N; Takagi K; Miki Y; Sasano H; Visvader JE; Lindeman GJ; Funder JW; Fuller PJ; Simpson ER; Tilley WD; Leedman PJ; Graham J; Muscat GE; Clarke CL; Clyne CD
    Breast Cancer Res Treat; 2013 Nov; 142(1):211-23. PubMed ID: 24122391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance in breast cancer of a gene signature capturing stromal PDGF signaling.
    Frings O; Augsten M; Tobin NP; Carlson J; Paulsson J; Pena C; Olsson E; Veerla S; Bergh J; Ostman A; Sonnhammer EL
    Am J Pathol; 2013 Jun; 182(6):2037-47. PubMed ID: 23583284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment.
    Sakurai M; Miki Y; Takagi K; Suzuki T; Ishida T; Ohuchi N; Sasano H
    Breast Cancer Res; 2017 Jun; 19(1):70. PubMed ID: 28629450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-expression of parathyroid hormone related protein and TGF-beta in breast cancer predicts poor survival outcome.
    Xu C; Wang Z; Cui R; He H; Lin X; Sheng Y; Zhang H
    BMC Cancer; 2015 Nov; 15():925. PubMed ID: 26597083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asporin is a stromally expressed marker associated with prostate cancer progression.
    Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
    Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.
    Tanaka M; Ichikawa-Tomikawa N; Shishito N; Nishiura K; Miura T; Hozumi A; Chiba H; Yoshida S; Ohtake T; Sugino T
    BMC Cancer; 2015 Feb; 15():53. PubMed ID: 25884418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.
    Hazelbag S; Kenter GG; Gorter A; Fleuren GJ
    Int J Cancer; 2004 Dec; 112(6):1020-8. PubMed ID: 15386352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
    Bierie B; Stover DG; Abel TW; Chytil A; Gorska AE; Aakre M; Forrester E; Yang L; Wagner KU; Moses HL
    Cancer Res; 2008 Mar; 68(6):1809-19. PubMed ID: 18339861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome.
    Miller P; Kidwell KM; Thomas D; Sabel M; Rae JM; Hayes DF; Hudson BI; El-Ashry D; Lippman ME
    Breast Cancer Res Treat; 2017 Nov; 166(1):85-94. PubMed ID: 28717852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.
    Busch S; Acar A; Magnusson Y; Gregersson P; Rydén L; Landberg G
    Oncogene; 2015 Jan; 34(1):27-38. PubMed ID: 24336330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.